turnstonebio.com (TSBX) - Gross Sales Margin

Official company branding of turnstonebio.com (TSBX)

The gross margin trend on the GURU.Markets chart demonstrates profitability dynamics, where 0.00 represents the latest metric reading. Turnstone Biologics (TSBX) is implementing automated benches to accelerate antibody testing. The development of TIL therapy for various tumor types minimizes regulatory risks. Additionally, the company is introducing robotic sample preparation to optimize cell selection and shorten clinical trial timelines.

Turnstone Biologics Corporation (TSBX) - Gross Margin from 02/21/2024 to 08/24/2025

Analytical breakdowns and data insights for company Turnstone Biologics Corporation (TSBX)

- stock value and consensus price forecast:
Fundamental valuation:Turnstone Biologics
Signature product of Turnstone Biologics Corp

A comparative asset analysis requires an assessment of a business's ability to generate profit before administrative expenses. This metric measures the portion of revenue remaining after covering direct production costs, which determines the fundamental efficiency of the operating model. For Turnstone Biologics (TSBX), this parameter depends directly on the cost of creating TIL therapy; therefore, the effective gross margin trend reflects the platform's scalability in treating solid tumors.